The exploration of stem and progenitor cells holds promise for advancing our understanding of the biology of tissue repair and regeneration mechanisms after injury. This will also help in the future use of stem cell therapy for the development of regenerative medicine approaches for the treatment of different tissue-specie defects or disorders such as bone, cartilages and tooth defects or disorders. Bone is a specialized connective tissue, with mineralized extracellular components that provide bones with both strength and rigidity, and thus enable bones to function in body mechanical supports and necessary locomotion process. New insights have been added to the use of different types of stem cells in bone and tooth defects over the last few years. In this concise review, we briefly describe bone structure as well as summarize recent research progress and accumulated information regarding the osteogenic differentiation of stem cells, as well as stem cell contributions to bone repair/regeneration, bone defects or disorders and both restoration and regeneration of bones and cartilages. We also discuss advances in the osteogenic differentiation and bone regeneration of dental and periodontal stem cells as well as in stem cell contributions to dentine regeneration and tooth engineering. This article is
Introduction
Stem cells can continuously produce unaltered daughters and could generate cells with different and more restricted properties. Stem cells can divide either symmetrically (allowing the increase of stem cell number) or asymmetrically. Asymmetric divisions keep the number of stem cells unaltered and are responsible for the generation of cells with different properties. These cells can either multiply (progenitors or transit amplifying cells) or be committed to terminal differentiation (Morrison and Kimble, 2006; Berika et al., 2014; Elshahawy et al., 2016; El-Hashash, 2015) .
Progenitors and transit amplifying cells have a limited lifespan and therefore can only reconstitute a tissue for a short period of time when transplanted. In contrast, stem cells are self-renewing and thus can generate any tissue for a lifetime. This is a key property for a successful therapy. The capacity to expand stem cells in culture is an indispensable step for regenerative medicine, and a considerable effort has been made to evaluate the consequences of the cultivation on stem cell behavior. Scientists rely on indirect properties to identify stem cells such as the expression of a repertoire of surface proteins, slow cell cycle, clonogenicity, or an undifferentiated state. The evaluation of self-renewal is the ultimate way to show "stemness", which relies on the isolation and transplantation of a putative stem cell (clonal analysis) followed by its serial transplantation and long-term reconstitution of a tissue (He et al., 2009 ).
Recently, stem cells have been used extensively in many medical disciplines for the repair and/ or regeneration of defective tissues and organs (e.g. bone, ligament, heart). New therapeutic approaches are largely inspired and based on our knowledge of embryonic development. The goal of regenerative medicine is to stepwise re-create in vitro all the mechanisms and processes that nature uses during initiation and morphogenesis of a given organ. In this context, stem cell research offers an amazing and seductive potential for body homeostasis, repair, regeneration and pathology. The possibility of manipulating stem cells in situ using specific signalling molecules or by expanding them ex vivo is an exciting outcome of basic research.
Hence, regenerative medicine has become a fashionable field and the isolation and manipulation of embryonic and adult (or post-natal) stem cells for the creation of new functional organs that will replace the missing or defective organs constitutes an enormous challenge. Adult stem cells (ASC), which possess a restricted potential of differentiation, can easily be isolated from a patient and after in vitro amplification and/or differentiation could be re-injected to the same patient thus avoiding immune rejection, as is the case for allografts or xenografts. However, the knowledge in stem cell technology is increasing quickly in all medical disciplines and dictates the need for new strategic approaches in all fields, including reparative dentistry. Stem cells have a great hope for various tissue repair, regeneration and engineering as well as for treatments of different human diseases (Mimeault and Batra, 2006; Caplan, 2007) .
Structure of the bone
The bone is a rigid organ that support and protect the various organs of the body, produces red and white blood cells, store minerals and enable mobility as well as support for the body. Bone is a specialized type of dense connective tissue as its extracellular components is mineralized to provide strength and rigidity. This makes it capable to fulfil its major role in supporting the whole body mechanically and in locomotion (Weatherholt et al., 2012) . It gives attachment to skeletal muscles, protects organs and plays a significant role in mineral homeostasis, particularly calcium and phosphorus (de Baat et al., 2005; Bayliss et al., 2012) .
Osteon is regarded as the building unit of a bone. It consists of concentric lamellae around a Haversian canal.
Osteons are connected to each other and to the periosteum by oblique channels called volkmann's canals.
The space between osteons is occupied by interstitial lamellae which are remnants of osteons that were partially resorbed during the process of bone remodelling (Bayliss et al., 2012) .
There are two types of osseous tissue; the solid cortical compact bone tissue and the cancellous bone or spongy bone. The solid cortical compact bone tissue is the hard-outer layer of the bone. It is one of the two types of osseous tissue that form bones. It forms 80% of osseous mass; provide levers for movements and store and release chemical elements mainly calcium (Marieb, 1998) . The cancellous bone, also known as trabecular or spongy bone, is found at the ends of long bones, as well as in the pelvic bones, ribs, skull, and the vertebrae. It has many pores covering 50-90 % of its volume. These pores give it spongy honeycomb-like appearance. Cancellous bone is highly vascular and frequently contains red bone marrow where haematopoiesis occurs (Marieb, 1998; Weatherholt et al., 2012; Gdyczynski, 2014) .
The periosteum that lines surfaces of bone is divided into two layers; an outer fibrous layer and an inner cambium or osteogenic layer. The fibrous layer contains fibroblasts while the cambium layer is in contact with the bone. It contains the progenitor cells, which develop into osteoblasts (Weatherholt et al., 2012) .
Matrix of the bone
It is the intercellular substance of bone tissue. It consists of collagen fibres, ground substance and inorganic bone salts. Type I collagen provides bone with its flexibility and is the main component of its organic portion. The remainder is made up of osteoids, proteoglycans and non-collagenous proteins including fibronectin, osteocalcin, osteonectin, thrombospondin and matrix-gla-protein. Fibronectin is abundant and regulates osteoblast differentiation while osteonectin regulates mineralization. Thrombospondin inhibits bone cell precursors while osteocalcin binds calcium. Lastly, matrix-gla-protein prevents mineralization. On the other hand, the inorganic portion of the bone matrix acts as an ion reservoir (Weatherholt et al., 2012) .
The matrix is mostly made up of a composite material incorporating the inorganic minerals including calcium phosphate in the chemical arrangement termed calcium hydroxylapatite [Ca10 (PO4)6 (OH)2], which is the bone mineral that gives bones their rigidity, fluoride, sodium, potassium, and magnesium in addition to collagen which is an elastic protein that improves its fracture resistance. Bone stiffness and flexibility are provided by its collagen and minerals (Weatherholt et al., 2012; Bayliss et al., 2014) .
Cellular elements of the bone
The major cell types of bone are osteoblasts (OBs), osteoclasts (OCs), and osteocytes (Kartsogiannis, 2004) .
The haematopoietic stem cells (HSCs) and mesenchymal stem cells (MSCs) give rise to the osteoclasts that modulate bone resorption and osteoblasts that mediate bone formation. Osteoblasts are necessary for bone reconstruction (Weatherholt et al., 2012) . The human skeleton integrity and strength are dependent on a delicate balance between bone formation by osteoblasts and bone resorption by osteoclasts. This balance is affected by various types of genetic and mechanical alterations. Degenerative skeletal diseases, including osteoporosis, become increasingly prevalent during human life. Osteoporosis, for example, reflects a relative preponderance of osteoclast activity and bone resorption exceeds bone formation (Weatherholt et al., 2012) .
MSCs are defined as self-renewing and multipotent cells capable of differentiating into multiple cell types including osteocytes and chondrocytes. MSCs were originally isolated from the bone marrow stroma but they have recently been identified also in other tissues such as fat, epidermis and cord blood. It remains in a non-proliferative, quiescent state until stimulated by the signals triggered by tissue renewal, damage and remodelling process. Development of MSCs is associated with mesodermal sclerotome condensation that subsequently differentiates into other cell types for bone remodelling. Stimulatory factors are needed for MSCs. They are derived from osteoblastogenesis such as the bone morphogenetic protein (BMPs), which act as the starting inducer of osteoblastogenesis. Seven BMPs were discovered. Of these, six belong to the Transforming growth factor beta superfamily of proteins (TGFβ). MSCs which are derived from bone marrow fat plays a major role in accelerating bone fracture tackling as they are the precursors of osteoblasts (Quarto et al., 2001 ). Bone marrow contains both hematopoietic stem cells and MSCs. Bone marrow transplantation has been advocated as a potential future therapeutic modality for osteogenesis imperfecta (Horwitz et al., 2002) .
Remodeling of the bone
It is a lifelong skeletal dynamic process which occurs over several weeks and is performed by clusters of bone-resorbing osteoclasts and bone-forming osteoblasts arranged within the temporary anatomical structures known as the Basic Multicellular Units (BMU), which consist of osteoclasts, osteoblasts, and osteocytes (Kular et al., 2012) . In the BMU, the amount of bone destroyed by osteoclasts is equal to the amount of bone formed by osteoblasts (Lips et al., 1978) . Mature bone tissue is removed from the skeleton (a process called bone resorption) and new bone tissue is formed (a process called ossification). These processes control the reshaping or replacement of bone following fractures and micro-damage which occurs during normal activity. An imbalance in the regulation of bone remodeling's two sub-processes, bone resorption and bone formation, results in many metabolic bone diseases such as osteoporosis (Raggatt et al., 2010) . Moreover, bone remodelling is a life-dominant process, where cortical and trabecular bone is rebuilt, and it plays a crucial role in bone mass balance and mineral homeostasis (Tolar et al., 2004) . Intriguingly, non-BMU cells, including T-cells, B-cells, and nerve cells also play an important role in bone remodelling (Gillespie et al., 2007; Horowitz and Lorenzo, 2007; Elefteriou, 2008) .
The remodelling mechanism of the bone includes initiation phase, reversal phase and termination phase.
Initiation phase is the first process in the remodelling cycle, in which osteoclast precursors are recruited and differentiated into mature osteoclasts to maintain bone resorption. Reversal phase is associated with bone resorption inhibition and the osteoblasts are recruited and started to be differentiated. Termination phase is the final step in the cycle which occurs when an equal quantity of resorbed bone has been replaced, the remodelling cycle concludes (Kular et al., 2012, Raggatt and Partridge, 2010) . Finally, there is a connected network among each of those cells and the osteocytes (Kular et al., 2012) . This phase is based on a mechanism that requires a key mediator called receptor activator of nuclear factor kappa-B ligand (RANKL), which is essentially required for osteoclastogenesis (Dougall et al., 1999; Palmqvist et al., 2002) . Ligandreceptor interaction of RANKL-RANK triggers the termination phase by promoting osteoclast precursor fusion and colony stimulating factor (CSF-1) (Arai et al., 1999; Parfitt et al., 2002; Lee et al., 2006; Tatsumi et al., 2007) . The BMU that comprises the remodelling process in the bone involves multiple Intercellular Much of bone turnover markers, that quantify bone resorption, are collagen breakdown products, telopeptides, and pyridinoline rings (Brown et al., 2009) . Deoxypyridinoline (DPD) is released into the circulation after resorption of bone matrix and thereafter is excreted in urine (Garnero and Delmas, 2004) .
BMU at the initiation, reversal (transition) and termination phases of bone remodelling cycle.
Osteogenic differentiation of stem cells
Identification and isolation of osteoprogenitor cells and other stem cell types that are capable of osteochondral differentiation to inform both bone repair and regeneration is a subject of several recent studies. For instance, human adipose tissue-derived mesenchymal stem cells (hAMSCs) are capable to both differentiate into osteoblasts and produce bone matrix of bone marrow derived stem cells (Tognarini et al., 2008) . Moreover, Olivares-Navarrete et al. (2010) have shown that human mesenchymal stem cells (MSCs) can differentiate into osteoblasts when growing on Titanium surfaces with microscale roughness even if the culture medium lacks osteogenic components. It has also been shown that nanostructured Titanium alloys (Ti6Al4V and Ti13Nb13Zr) can sustain the proliferation, growth and adhesion of hAMSCs. These alloys also promote the osteogenic differentiation of hAMSCs (Marini et al., 2015) . In addition, a recent study by Gothard and co-workers has shown that regionally-derived cell populations and skeletal stem cells from human fetal femora exhibit specific osteochondral and multi-lineage differentiation capacity both ex vivo and in culture (Gothard et al., 2015) . Growth factors and extracellular matrix proteins also play important roles in the osteogenic differentiation of stem cells. For instance, a recent research by Wang Y et al. (2016) has investigated the positive and reciprocal effect of TGF-β3 on BMP-2 growth factor in promoting osteogenic differentiation, based on an early study by (Haschtmann et al., 2012 ) that showed that co-delivery of BMP-2 and TGF-β3 is more effective than single gene-transfection in promoting ossification of the annulus fibrosus. Wang and coworkers simultaneously expressed BMP-2 and TGF-β3 genes in rabbit bone marrow-derived mesenchymal stem cells. Then, they measured the expression status of both BMP-2 and TGF-β3 in culture to elucidate whether these growth factors can be synergistically expressed in vivo. This study has demonstrated a synergistic effect of the overexpression of BMP-2 and TGF-β3 on osteogenic differentiation of bone marrow mesenchymal stem cells Wang et al. (2016) . In addition, Polini et al. (2014) have developed a strategy, based on in situ delivery of growth factor-inspired peptides through their immobilization onto Hydroxyapatite (HA), which is the principal component of bone mineral, surfaces. This study found that stable biofunctionalization of HA surfaces by HA-binding/osteogenic modular peptides induces osteogenic differentiation of mesenchymal stem cells (Polini et al., 2014) .
Stem cell contributions to bone repair and regeneration
Several reports have shown that mesenchymal stem cells (MSC) that are derived from periosteum and bone marrow are involved in fracture repair. They have also shown that the impairment of bone regeneration is probably due to a damage of the surrounding skeletal muscle (reviewed in Owston et al., 2016) . For example, a recent study from Cao's laboratory (Islam et al., 2016) has shown that fluorescently labelled human embryonic stem cells-derived osteoprogenitors (hESC-OPs) are able to maintain both their GFP expression for the long term and their potential for osteogenic differentiation in culture. This will help in the future application of these fluorescently labelled hESC-OPs in the noninvasive assessment of bone regeneration and therapeutic efficacy.
Bone marrow stem cells can grow in vitro, and cultured bone marrow osteoprogenitors can be used for bone regeneration after seeding on an appropriate scaffold material, as shown in Figure ( 2). Most recently, Chen et al. (2017) have shown evidences of a successful angiogenic and osteogenic regeneration in rats via calcium phosphate scaffold (CPC) and endothelial cell co-culture with human bone marrow MSCs (hBMSCs), human umbilical cord MSCs (hUCMSCs), induced pluripotent stem cells (hiPSC-MSCs) and embryonic stem cells (hESC-MSCs). Thus, co-cultures of hUVECs with hUCMSCs, hiPSC-MSCs, hESCMSCs and hBMSCs delivered via CPC scaffold have achieved excellent osteogenic and angiogenic capabilities in vivo (Chen et al., 2017) . These co-culture constructs will provide promising solutions for bone reconstruction with improved angiogenesis for both orthopedic and craniofacial applications. Similarly, a recent study has shown a successful bone regeneration in minipigs via calcium phosphate cement scaffold delivering autologous bone marrow mesenchymal stem cells (BMSCs) and autologous platelet-rich plasma (Qiu et al., 2017) . Another approach that has also been reported to be successful for prompting bone regeneration is the incorporation of a bone marrow-derived mesenchymal stem cell (BMSC) sheet into the platelet-rich plasma (PRP) gel/calcium phosphate particles, which will offer effective therapeutic strategies for promoting the clinical repair of bone defects (Qi et al., 2015) .
Furthermore, a most recent research by Joo et al. has compared bone regeneration using allogeneic cancellous bone granule scaffolds loaded with autologous bone marrow-derived mesenchymal stem cells (BM-MSC) with or without autologous platelet-rich plasma (PRP), and showed a similar progression of new bone formation and maturation (Joo et al., 2017) . Furthermore, several recent reports have highlighted the advantages of adipose-derived stem cells (ASCs) over other stem cells that are derived from bone marrow. These advantages include a higher number of stem cell progenitors from an equivalent amount of tissue harvested, a less invasive procedure of cell harvesting, a significate increase of both proliferation and differentiation capacities, as well as better osteogenic/angiogenic properties in vivo (Dufrane, 2017) .
Stem cell contributions to bone defects and both restoration and regeneration of bones and cartilages
The cranial and facial bone defects are complicated, particularly because of the difficulty of finding an appropriate autologous bone transplant for them. Current treatments of these defects using stem cells have been successful, and their safety have been proved using preclinical experiments. For instance, several reports have shown the effective functions of adipose-derived stem cells in the experimental treatment of different types of bone defects (reviewed by Seppänen and Miettinen, 2014 ).
Bone marrow-derived mesenchymal stem cells (BMSC) are also important cell population for bone tissue repair, engineering and regeneration. Addition of recombinant human bone morphogenetic protein (rhBMP-2) to a silica-coated calcium hydroxyapatite (HASi)-rabbit BMSC (rBMSC) construct could promote bone healing and regeneration in a large critical-size-defect in rabbits (Maiti et al., 2016) .
Umbilical cord mesenchymal stem cells (UCMSCs) and amniotic fluid-derived stem cells (AFSCs) are also attractive cell populations for bone repair/regeneration as well as promising candidates for cell therapy and tissue engineering. In a recent study from Liu's laboratory, UCMSCs were transplanted into the bone defect peri-implant, and were capable to promote bone repair/regeneration and new bone formation (Hao et al., 2014) . In contrast, both the experimental and preclinical applications of AFSCs in bone repair/regeneration, including maxillofacial bone tissue engineering, are still limited. However, a recent study by Wang and others (Wang et al., 2017) has proposed an AFSCs-based bone tissue engineering strategy for congenital alveolar cleft restoration. This study has evaluated the regenerative properties of AFSCs in restoration of alveolar bone defect, and provided evidences of the feasibility of an AFSCs-based alveolar bone tissue engineering strategy for alveolar defect restoration (Wang et al., 2017) .
Similarly, stem cells are a highly promising tool for new developments in cartilage tissue regeneration. Both ex vivo expanded chondrocytes and BMSC are currently extensively used in the regeneration of damaged cartilages. BMSC are the most used stem cell source in the engineering and repair of cartilage tissues (Georgi et al., 2014; Tritz-Schiavi et al., 2010) . However, the use of autologous BMSC have certain limits, including possible damage of donor site, painful collection methods, low number of available BMSC, and the decrease of both their proliferation capacity and differentiation potential with age (Pittenger et al., 1999; Zaim et al., 2012; Fossett et al., 2012) . To help with sorting out these difficulties, Reppel and his colleagues have attempted to identify alternative sources of MSC in cartilage tissue repair/engineering (Reppel et al., 2015) . They have evaluated the chondrogenic potential of mesenchymal stromal/stem cells from Wharton's jelly (WJ-MSC), which were embedded in alginate/hyaluronic acid (Alg/HA) hydrogel, compared to the potential of BMSC. This study has found that WJ-MSC, embedded in a three-dimensional environment, were able to adapt to their environment and express specific cartilage-related genes and matrix proteins and, therefore, represent a promising alternative stem cell source for cartilage tissue engineering (Reppel et al., 2015) . Another new replacement cell source for cartilage repair is human induced pluripotent stem cells (hiPSCs), mostly because of their multipotency and unlimited self-renewal ability. Nam and others (2017) have mostly recently reported the characteristics of cartilage-like chondrogenic pellets generated from cord blood mononuclear cell-derived hiPSCs (CBMC-hiPSCs), suggesting these cells as a potential cell source for cartilage repair and regeneration.
Osteogenic differentiation and bone regeneration of dental and periodontal stem cells
Human periodontal ligament (PDL) represents a unique reservoir of stem cells because it contains a unique population of multipotent stem cells, which have the capacity to differentiate and form cells with diverse phenotypes (Mrozik et al., 2010) . Moreover, Seo et al. (2004) have shown that periodontal ligament stem cells (PDLSCs) that are transplanted in nude mice, can form an ectopic cementum/ligament-like complex.
Tissue regeneration mediated by human PDLSCs (Figure 3) represent a promising practical cell-based treatment for various periodontal diseases (Tamaki et al., 2013; Figure 3 ). In addition, a study from Meng's laboratory (Zhang et al., 2014) has aimed to investigate human PDLSCs for their stem cell characteristics via analysis of cell surface marker expression, colony forming unit efficiency, osteogenic differentiation and adipogenic differentiation, and compared to BMSCs. This study has suggested that BMSCs owned the stronger immunomodulation in local microenvironment via anti-inflammatory functions, compared to PDLSCs (Zhang et al., 2014) . In addition, Chen et al. (2015) has used the indirect co-culture approach to elucidate the effects of PDLSCs on differentiation of osteoblast-like cells and osteoclast precursors in culture, and found that PDLSCs promote osteoblastic differentiation of osteoblast precursors and osteoclastic differentiation of osteoclast precursors.
Dental pulp stem cells (DPSCs) are derived from neural crest cells and represent one of the most widely used seed cells in the field bone tissue engineering/regeneration for several reasons, including their easily isolation, low immunogenicity, lack of ethical controversy and reduced rates of transplantation rejection (Pierdomenico et al., 2005; Huang et al., 2009; Sakai et al., 2012) . DPSCs show MSC characteristics and can differentiate into many cell types, including odontoblasts, osteoblasts, chondrocytes. DPSCs are, therefore, capable of differentiation into bone cells, promoting both the regeneration and repair of alveolar bone defects (Huojia et al., 2015) . de Mendonca et al. (2008) have transplanted human DPSC into large rat calvarial defects and found that they can differentiate into osteogenic cells without rejection of the graft. Moreover, dense collagen gel scaffolds seeded with rat DPSC (rDPSC) that were implanted in a rat critical-sized calvarial defect model have accelerated both osteogenic DPSC differentiation and craniofacial bone regeneration (Chamieh et al., 2016) .
Other types of stem cells may also important in bone regeneration. A recent research by Szepesi et al. (Szepesi et al., 2016) has aimed to compare the properties of differentiated human MSCs from adult adipose tissue (AD-MSCs), Wharton's jelly of the umbilical cord (WJ-MSCs), and Periodontal ligament stem cells (PDLSCs) that were grown in culture. This study has also investigated the combined in vitro osteogenic and endothelial differentiation capacities of MSCs that were derived from Wharton's jelly, adipose tissue, and periodontal ligament, and found that MSCs that were isolated from periodontal ligament and adipose tissue are probably most appropriate for the generation vascularized bone graft Szepesi et al., 2016) . Indeed, a recent experimental study in the dog has suggested adipose-derived stem cells as a tool for dental implant osseointegration (Bressan et al., 2015) . Moreover, dental follicle (DF) stem cells have been shown to have a spontaneous tendency for osteogenic differentiation, and were suggested for bone regeneration (Lucaciu et al., 2015) .
Stem cell contributions to dentine regeneration and tooth engineering
Tooth development results from sequential and reciprocal interactions between both the oral epithelium and the underlying neural crest-derived mesenchyme. The manipulation of stem cells is important for the generation of dental structures in the laboratory. This dental structure generation requires better understanding of the synergy of molecular and cellular events and mechanisms that are involved in the formation of various tooth-specific hard tissues, dentin and enamel.
Over the past decade, the dental field has benefited from recent findings in stem cell biology and tissue engineering that led to the elaboration of novel ideas and concepts for the regeneration of dental tissues or entire new teeth. Stem cell-based regenerative approaches are, therefore, extremely promising since they aim at the full restoration of lost or damaged tissues, ensuring thus their functionality. These therapeutic approaches are already applied with success in clinics for the regeneration of other organs and consist of manipulation of stem cells and their administration to patients. Stem cells have the potential to self-renew and to give rise to a variety of cell types that ensure tissue repair and regeneration throughout life (Miran et al., 2016) .
Mammalian teeth contain mesenchymal stem cells (MSCs) that contribute to both tooth growth and repair, and are characterized by both their accessibility and clinical relevance that provide a valuable opportunity to test stem cell-based treatments for dental defects (Sharpe, 2016) . These dental MSCs show similar features to bone marrow-derived MSCs in culture, such as expression of certain markers, and clonogenicity, as well as differentiation into cells that have the characteristics of chondrocytes, osteoblasts and adipocytes. Teeth and their support tissues provide both easily accessible source of MSCs and a tractable model system to investigate them in vivo properties and function. (Sharpe, 2016) . Different types of MSCs have been extensively investigated for their capacity to form dentin in culture. In contrast, more studies are still needed for understanding the applications of epithelial stem cells in tooth regeneration, particularly because odontogenic potential resides in the oral epithelium and, therefore, epithelial stem cells are critical for tooth formation and production of enamel matrix.
Tooth regeneration through stem cell-based therapy is a promising treatment for tooth decay and loss.
Human dental pulp stem cells (hDPSCs) have been widely identified as the stem cells with the most potential for tooth tissue regeneration. However, growing culture of hDPSCs in culture for tissue engineering is still a challenge because cells may differentiate poorly and/or proliferate slowly in vivo. Dynamic three-dimensional (3D) simulated microgravity (SMG) created using the rotary cell culture system is considered to an effective tool, which contributes to several cell functions. A recent study by Li et al. (2017) has used various histological and immunohistochemical examinations of Ki-67, dentin sialoprotein, type I collagen and DMP-1, and found that both the proliferation and odontogenic differentiation abilities of the hDPSCs that were prepared in the 3D SMG culture system were higher, compared with those prepared in the static culture system. These results suggested that dynamic 3D SMG abilities of hDPSCs in vivo (Li et al., 2017) .
Stem cell therapy is currently considered as a potential strategy to regenerate the dentin-pulp complex, enabling the conservation and restoration of functional teeth, and both standardization and establishment of regulatory guidelines for stem cell therapy in clinical endodontics are a subject of intensive research. One of the key factors that induces subsets of dental pulp stem cells to form mobilized dental pulp stem cells (MDPSCs) is granulocyte-colony stimulating factor (G-CSF). It is well-established that good manufacturing practice is a prerequisite for both isolation and expansion of MDPSCs, which are enriched in stem cells that extensively express trophic factors with properties of high migration, proliferation, and antiapoptotic effects and endowed with regenerative potential. Nakashima and co-workers (2014) have found that autologous transplantation of MDPSCs with G-CSF in pulpectomized teeth in dogs augmented the regeneration of pulp tissue. In this research, the quality of clinical-grade MDPSCs was confirmed by the absence of karyotypic abnormalities and the lack of tumor formation after transplantation in immune-deficient mice. This study has confirmed the combinatorial trophic effects of MDPSCs and G-CSF on cell migration, immunosuppression, anti-apoptosis, and neurite outgrowth were in culture, as well as has established the preclinical safety, feasibility, and efficacy of pulp regeneration by MDPSCs and G-CSF (Nakashima et al., 2014) .
Most recently, Qi et al. (2017) have demonstrated that the proliferation of hDPSCs was stimulated after delta-like homologue (DLK1) overexpression, which suppressed the odontoblastic differentiation of hDPSCs, probably through ERK signaling pathway. Both DLK1 and p-ERK1/2 were strongly expressed on the odontoblasts and dental pulp cells on the first maxillary molar, and DLK1 expression levels increased after the odontoblastic induction of hDPSCs (Qi et al., 2017) .
Dental pulp stem cells also play an important role in pulp revascularization. The pulp vascular system actively contributes to waste removal, nutrient supply, and both pulp inflammatory response and subsequent regeneration. Under hypoxic stress, dental pulp cells release proangiogenic factors such as vascular endothelial growth factor. Exogenous vascular endothelial growth factor has widely applied in tissue engineering (reviewed in Rombouts et al., 2017) . It has been demonstrated that dental pulp stem cell secretome possesses angiogenic potential, which can contribute to the angiogenic process in different ways such as differentiating themselves into the endothelial lineage and guiding endothelial cells (Rombouts et al., 2017) .
Progenitor stem cell niches also exist in the post-natal pulp, and have important functions in both dentine formation and wound healing. Progenitor stem cell niches have a multi-potentiality property and, therefore, can differentiate osteoblasts and chondrocytes in response to specific stimuli (Sloan and Waddington, 2009 ).
They can also differentiate into odontoblasts and, therefore, are considered as a natural reparative mechanism. This can be triggered by an inflammation, injury or trauma that also affects their proliferation activities. For instance, inflammations in the dental regions have been found to associate with recruitment of tooth progenitor cells that migrate to the injury regions from their niches to stimulate the repairing mechanisms (Téclès et al., 2005) . In addition, (Løvschall et al. (2005) have investigated stem cell niches in vivo by Notch expression increment followed by pulpal injury. These experiments added further niches to the perivascular ones (Løvschall et al., 2005) .
Dental pulp stem cells and age-related changes
Aging is the progressive decline of physiological integrity that leads to age-related degenerative diseases.
Dental pulp has several functions, including pulp cell activity involvement in dentin formation. Several changes have been reported during the aging process, including a progressive reduction of the pulpal chamber size, a progressive deposition of calcified masses in the root and coronal pulp, and fewer nerves, cells and blood vessels within the pulp, as well as an increase in the fibrous component (Pashley et al., 1994) .
In addition, both pulpal wound healing and cell regeneration are probably compromised with increasing age because of a sever reduction of potential stem/progenitor cell number in the dental pulp (Smith et al., 2005) .
The causes of dental pulp aging are unclear. It is still not clear whether age-related changes are due to intrinsic factors that exit during cell aging or are induced through extrinsic factors of the somatic environment (Sethe et al., 2006) . Development of aging-related molecules in pulp cells requires better understanding of cellular and molecular mechanisms that are responsible for tooth preservation and maintenance strategies. Lee et al. (2013) have investigated human dental pulp cells (hDPCs), and found that replicative senescence, which is often thought to be synonymous with aging, of these cells was characterized by both senescenceassociated β-galactosidase activity and reactive oxygen species formation. This study has further shown that hDPCs exhibited altered expression of several chronic inflammatory molecules, including peroxisome proliferator activated receptor-gamma, vascular cell adhesion molecule-1, intracellular adhesion molecule-1, and heme oxygenase-1 and age-related molecules such as p53, p21, phosphorylated-extracellular signalregulated kinase, and c-myb. Furthermore, hDPCs decreased odontogenic markers such as dentin matrix-1 and osteogenic markers such as bone morphogenetic protein-2 and -7, runt-related transcription factor-2, osteopontin, alkaline phosphatase activity, and mineralized nodule formation by replicative senescence (Lee et al., 2013) .
Human DPSCs (hDPSCs) are characterized by their rejuvenated capacity that relies on its resident stem cells.
Until most recently, identification of the underlying molecular mechanisms that control dental pulp stem cells senescence and aging was hindered, mostly because of the lack of proper senescence models. Zhai and his colleagues (Zhai et al., 2017) have recently identified these age-related phenotypic changes by augmented senescence-associated-β-galactosidase (SA-β-gal) staining, elevated G0/G1 cell cycle arrest, increased apoptosis, and declined proliferation and differentiation capacity, as well as reactive oxygen species levels. This study has also shown that dental pulp stem cells from young donors are more resistant to apoptosis and exhibit increased non-homologous end joining activity compared to old donors. They have also shown that induced dental pulp stem cells ageing is dependent on several factors and pathways such as genes associated with DNA damage and repair, mitochondrial dysfunction and increased reactive oxygen species levels (Zhai et al., 2017) .
Another type of stem cells, mesenchymal stem cells derived from human dental pulp (DP-MSCs), are characterized by self-renewal and multi-lineage differentiation and play important functional roles in regenerative medicine. The safest approach in cellular transplantations is autologous transfer, as nonimmunogenic. However, the applications of this autologous transfer in regenerative medicine may be limited by age-related changes (Feng et al., 2014) . Indeed, several studies have reported a decrease in the osteogenic differentiation potential of MSC and an increase of MSC adipogenic potential with age, which has been coined as the adipogenic switch (D'Ippolito et al., 1999; Bergman et al., 1996; Ross et al., 2000; Stolzing et al., 2008) .
The age-related changes also influence mesenchymal stem cells (MSCs). The regenerative abilities of MSCs show an age-associated decline, probably due to several age-related changes in MSC number, intrinsic properties of MSCs and extrinsic factors of the extracellular environment (the stem cell niche). Until recently, variable methods of MSC isolation and variations in stem cell populations have hindered investigations of the effect of age on the efficacy of MSC transplantation on regeneration. However, a study by Iohara et al. (2014) has provided a better understanding of the mechanisms involved in the age-dependent decline in pulp regeneration that are attributed to a decrease in the regenerative potential of resident stem cells. This study has demonstrated that MDPSCs from aged dogs were efficiently enriched in stem cells, expressing trophic factors with high migration, proliferation, and anti-apoptotic effects as in MDPSCs from young dogs. This research has, however, shown that pulp regeneration was retarded 120 days after autologous transplantation of aged MDPSCs. In addition, they have found that isolated periodontal ligament stem cells (PDLSCs) from aged dogs, which are representative of migrating stem cells from outside of the tooth compartment to regenerate pulp tissue, show lower migration, proliferation and anti-apoptotic abilities .
Conclusions and future directions
In conclusion, this review has shown that different stem cell types, including human MSCs, and hAMSCs can differentiate into bone cells. Identification and isolation of these stem cell types and osteoprogenitor cells that are capable of osteochondral differentiation to inform both bone repair and regeneration are a subject of intensive recent studies that have been summarized in this review. The significant contributions of these various stem cell types in bone repair and regeneration, bone defects and both restoration and regeneration of bones and cartilages as well as dentine regeneration and tooth engineering were also discussed in the current review. The strategy of stem cell regeneration will probably provide new clinical solutions and interventions for various types of bone and tooth defects/disorders. However, to apply this new strategy, further studies are still required to fully understand stem cell behavior, and regulatory mechanisms and machineries, as well as stem cell functions and mechanisms in the treatment of various types of bone/tooth defects or disorders.
Understanding these functions and mechanisms may help to identify novel targets for the prevention and rescue therapy of fatal bone disease in infancy and childhood and for bone regeneration after injury. In addition, future studies on the identification of molecular programs that control osteogenic differentiation of stem cells will be crucial for developing techniques that harness the ability of these cells to regenerate diseased and damaged bones and teeth.
Currently, there are many potential clinical studies that focus on the engineering of the entire tooth.
However, the engineering of the entire tooth currently face several major challenges, including the ability to control tooth shape and size. Furthermore, the conversion of the current research approaches of stem cells identification and characterization within the dental regions into applied clinical strategies is still also a major challenge. Further studies are needed for the development of these novel approaches because they can not be easily applied clinically for various reasons such the complexity of regeneration protocols for the injured pulp. Further studies are also needed to evaluate the applications of dental progenitor stem cells and to determine whether this stem cell approach can be successfully translated into clinic. 
